24/7 Clients Support
| Brand Name | APRELIEVA 125MG |
| Composition | Aprepitant Capsules IP 125mg |
| Manufacture By | Allieva Pharma Private Limited |
| Form | Capsule |
| Packing | KIT |
| Country Of Origin | India |
| Description | APRELIEVA contains Aprepitant, an antiemetic drug belonging to the Neurokinin-1 (NK1) receptor antagonist class. It works by blocking substance P in the brain, thereby preventing chemotherapy-induced nausea and vomiting (CINV). |
| Uses | Aprepitant is used for: 1. Prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV) 2. Prevention of postoperative nausea and vomiting (PONV) (selected cases) 3. Used in combination with 5-HT3 antagonists (e.g., ondansetron) and corticosteroids |
| Side Effects | Common side effects: • Fatigue • Hiccups • Constipation or diarrhea • Headache • Loss of appetite Less common / serious side effects: • Elevated liver enzymes • Allergic reactions (rare) |
| Dosage | For CINV (3-day regimen): • Day 1: 125 mg orally (before chemotherapy) • Day 2 & 3: 80 mg once daily Take 1 hour before chemotherapy on Day 1 |